glp 1 drugs for alcohol use disorder GLP-1 Agonists Disorder: UK Evidence and Guidance Frontiers | The therapeutic potential

Cilla DD Jr, Whitfield LR, Gibson DM, Sedman AJ, Posvar EL

Furthermore, the RCTs differed in DR-related criteria and methodology

Bu T, Sun Z, Pan Y, Deng X, Yuan G

Whether this distinct property of saxagliptin could interact with pathways of bone metabolism and bone turnover, thus having a relatively negative impact on bone mass or strength, needs to be elucidated

In rodents, GLP-1 has been shown to increase the biosynthesis of glucose transporter 2 (GLUT-2) and glucokinase [29]

Prospective studies and RCTs should be conducted in IBD patients with active inflammation to verify their immunomodulatory effects and assess whether they can be used therapeutically, either alone or as an adjunctive therapy